Navigation Links
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
Date:1/27/2009

First and Only Topical Gel Provides Ease, Efficacy and Excellent Tolerability

CORONA, Calif., Jan. 27 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leader in generic and specialty branded pharmaceuticals, announced today that the U.S. Food and Drug Administration (FDA) has approved GELNIQUE(TM) (oxybutynin chloride) Gel 10%, the first and only topical gel for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency. The U.S. OAB market currently exceeds $1.8 billion annually and continues to grow each year.

GELNIQUE will provide OAB patients with an effective and novel alternative to currently available oral treatment options. Because the active ingredient in GELNIQUE is delivered transdermally, it is not metabolized by the liver in the same way as orally administered oxybutynin. This results in a low level of side effects, such as dry mouth and constipation. GELNIQUE will be actively marketed to physicians, and Watson anticipates that the product will be made available to patients in the second quarter of this year.

"Based on the results of a clinical trial, which showed strong efficacy and excellent tolerability, and considering its unique delivery system, we expect that GELNIQUE will be used as a first-line therapy for the treatment of OAB," said Paul Bisaro, Chief Executive Officer of Watson. He added, "With this approval, which comes on the heels of the FDA approval of RAPAFLOTM (silodosin), a treatment for the signs and symptoms of benign prostatic hyperplasia (BPH), and the acceptance of the NDA for Watson's six-month formulation of TRELSTAR(R) for the palliative treatment of advanced prostate cancer, Watson is clearly establishing itself as a major force in Urology."

About GELNIQUE

GELNIQUE is a q
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
4. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
5. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
6. Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
7. EVICEL(TM) Fibrin Sealant (Human) Approved for General Hemostasis in Surgery
8. Clexane(R)/Lovenox(R) Approved in Japan
9. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
10. Center for Molecular Medicine Among First to Offer New FDA-Approved Test to Aid in Treatment of Prostate Cancer
11. Lucids VivaScope(R) Reflective Confocal Microscope Approved for Sale in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... VANCOUVER , May 27, 2015 /CNW/ - CQDM, ... award close to $8.5M to six (6) multi-disciplinary and ... in neuroscience within their Focus on Brain strategic initiative. ... research entities involved as in-kind contributions. This exciting announcement ... Canadian Association for Neuroscience in the presence of Inez ...
(Date:5/27/2015)... The ALS Therapy Development Institute ... subsidiary, Anelixis Therapeutics , $1.5 million toward the ... the innate immune system. The funding comes from the ... the 2014 social media phenomenon known as the “ALS ... raised directly by the Institute through last year’s Ice ...
(Date:5/27/2015)... , May 27, 2015  CytomX, a ... of cancer, today announced the appointments of ... Cynthia Ladd as senior vice president ... was chief financial officer of Onyx Pharmaceuticals, an ... independent consultant and legal counsel to several leading ...
(Date:5/27/2015)... 2015  Two years after its founding by a ... scientists, Oakland -based Counter Culture Labs ... mission to democratize science through a full-fledged community laboratory ... Photo - http://photos.prnewswire.com/prnh/20150526/218366LOGO ... Based out of the new Omni Commons ...
Breaking Biology Technology:Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 2Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 3Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 4Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 5Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 6Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 7Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 8Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 9Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 10Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 2Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 3CytomX Expands Executive Leadership Team 2CytomX Expands Executive Leadership Team 3East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 2East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 3
... looked at venture capital funding in the U.S. during ... billion in investments in small companies. , ,While promising, ... during the fourth quarter of 2003, according to ... second quarter of 2004 were a bit of a ...
... United States was hit with the largest blackout in ... holes in the grid that were previously unknown. Its ... preparing for a similar disaster has been placed on ... down a hundred power plants through the United States ...
... D. Flowers, right, who work for Milwaukee-based Johnson Controls, enjoyed ... Battery Company in St. Louis. On Tuesday, August 17th, ... threw an elaborate party at Milwaukee's Pabst Theater ... lot to be proud of. In the past year, 218 ...
Cached Biology Technology:Midwest life science companies capture 3% of VC investments in Q.2 2One year after the 2003 blackout: Is Wisconsin prepared? 2One year after the 2003 blackout: Is Wisconsin prepared? 3Young Professionals of Milwaukee Celebrates Its Third Birthday, Looks To The Future 2Young Professionals of Milwaukee Celebrates Its Third Birthday, Looks To The Future 3
(Date:5/18/2015)... , May 18, 2015 Fingerprint ... sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one if ... June until and including Q3 2015 and the sensors will ... . Communicated order values for 2015 hereby amount to 740 ... Q1 2015 of 140 MSEK and a number of smaller ...
(Date:5/11/2015)... 2015 Curemark LLC, a privately held drug ... new Phase III double blind, randomized, placebo-controlled clinical trial ... on all children ages 3-8 with Autism. Previously, Curemark ... double blinded clinical trial for CM-AT in children ages ... digestive enzyme chymotrypsin. This new trial will help determine ...
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, reminds investors ... Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA ... 5-7, 2015. The three-day conference is organized ... is speaking in is themed Global Fraud: Where is ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... Wildlife Conservation Society confirm the existence of more than 1.2 ... Sudan, where wildlife was thought to have vanished as a ... wildlife in Southern Sudan, last surveyed more than 25 years ... the Nile River in numbers that rival those of the ...
... use its own weapon, the immune system, to battle cancer" ... immunization. The production of a selective vaccine is not a ... the University of Mainz has now found a way to ... carrier protein without irritating the immune system. As they report ...
... father is not enough to keep an avian marriage together ... Galapagos Islands off the coast of Ecuador. , Many Nazca ... to a Wake Forest University study scheduled for publication in ... June 13. , This is surprising because there is ...
Cached Biology News:Massive herds of animals found to still exist in Southern Sudan 2Massive herds of animals found to still exist in Southern Sudan 3Massive herds of animals found to still exist in Southern Sudan 4Massive herds of animals found to still exist in Southern Sudan 5Massive herds of animals found to still exist in Southern Sudan 6Progress toward an antitumor vaccine 2Study investigates 'divorce' among Galapagos seabirds 2
... Freezerworks Unlimited includes 2 clients and streamlines sample ... sharing of freezers by multiple groups without the ... Network Client/Server version for Macintosh ... with 256 colors; OS 8.6 & OS 9.x ...
... 500 reactions. Prepare circular DNA templates ... microgram quantities of template DNA from ... DNA directly for cycle sequencing without ... liquid cultures, colonies, plaques, or purified ...
...
Request Info...
Biology Products: